HealthExec June 4, 2024
Earlier this year Elon Musk’s Neuralink—a technology project that uses brain implants for a variety of purposes, including as a medical device—revealed it had successfully completed its first human trial. Now, it appears the company has greatly expanded its workforce and is backed by some serious funding.
A new report from CB Insights found Neuralink has ramped up hiring, expanding its workforce by 120% over the last two years, including more than a 16% increase since that successful human trial.
Further, the company has received $680 million from investors to date, the report said.
That number likely rose after it was revealed that Neuralink’s technology works. In...
Today's Sponsors
Today's Sponsor